Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
MT-1 was originally developed as a potential therapeutic agent for conditions like erythropoietic protoporphyria (EPP) and other photosensitivity disorders, where increased melanin production could reduce UV-induced damage
They're prescription medications, completely legal when prescribed by a doctor
Expert Review of Clinical Pharmacology , 17 (8), 721729
Maintain (Weeks 58): Hold at 50 mcg daily
However, other studies that measured the CSF-to-plasma ratio have found that the CSF/plasma ratio for SHBG remains constant
US$ 26.04
US$ 24.37
/assets/images/provider/photos/2775905.jpeg)
US$ 26.82
US$ 26.06
US$ 25.00
